{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:42:46Z","timestamp":1786578166787,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10620-021-06848-z","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T14:36:22Z","timestamp":1613054182000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Protective Effect of Luminal Uric Acid Against Indomethacin-Induced Enteropathy: Role of Antioxidant Effect and Gut Microbiota"],"prefix":"10.1007","volume":"67","author":[{"given":"Akinori","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-4055","authenticated-orcid":false,"given":"Masaaki","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Tanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Komoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumie","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hokari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"6848_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","volume":"19","author":"M Oda","year":"2002","unstructured":"Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002;19:640\u2013653","journal-title":"Mol Biol Evol"},{"key":"6848_CR2","first-page":"125","volume":"20","author":"MA Hediger","year":"2005","unstructured":"Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005;20:125\u2013133","journal-title":"Physiology (Bethesda)"},{"key":"6848_CR3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.1780080429","volume":"8","author":"LB Sorensen","year":"1965","unstructured":"Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum 1965;8:694\u2013706","journal-title":"Arthritis Rheum"},{"key":"6848_CR4","doi-asserted-by":"publisher","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009;1:5ra11","journal-title":"Sci Transl Med."},{"key":"6848_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15257770.2013.854902","volume":"33","author":"T Takada","year":"2014","unstructured":"Takada T, Ichida K, Matsuo H, Nakayama A, Murakami K, Yamanashi Y et al. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides Nucleotides Nucl Acids 2014;33:275\u2013281","journal-title":"Nucleosides Nucleotides Nucl Acids"},{"key":"6848_CR6","doi-asserted-by":"publisher","first-page":"e30456","DOI":"10.1371\/journal.pone.0030456","volume":"7","author":"A Hosomi","year":"2012","unstructured":"Hosomi A, Nakanishi T, Fujita T, Tamai I. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2. PLoS ONE 2012;7:e30456","journal-title":"PLoS ONE"},{"key":"6848_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 2012;3:764","journal-title":"Nat Commun"},{"key":"6848_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1600-0773.2003.pto930606.x","volume":"93","author":"S Muraoka","year":"2003","unstructured":"Muraoka S, Miura T. Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol Toxicol 2003;93:284\u2013289","journal-title":"Pharmacol Toxicol"},{"key":"6848_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1749-6632.2002.tb04072.x","volume":"962","author":"M Whiteman","year":"2002","unstructured":"Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann N Y Acad Sci 2002;962:242\u2013259","journal-title":"Ann N Y Acad Sci"},{"key":"6848_CR10","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981;78:6858\u20136862","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6848_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/acn3.167","volume":"2","author":"H Matsuo","year":"2015","unstructured":"Matsuo H, Tomiyama H, Satake W, Chiba T, Onoue H, Kawamura Y et al. ABCG2 variant has opposing effects on onset ages of Parkinson\u2019s disease and gout. Ann Clin Transl Neurol 2015;2:302\u2013306","journal-title":"Ann Clin Transl Neurol"},{"key":"6848_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","volume":"9","author":"G Toncev","year":"2002","unstructured":"Toncev G, Milicic B, Toncev S, Samardzic G. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol 2002;9:221\u2013226","journal-title":"Eur J Neurol"},{"key":"6848_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jalz.2019.01.014","volume":"15","author":"L Scheepers","year":"2019","unstructured":"Scheepers L, Jacobsson LTH, Kern S, Johansson L, Dehlin M, Skoog I. Urate and risk of Alzheimer\u2019s disease and vascular dementia: a population-based study. Alzheimers Dement 2019;15:754\u2013763","journal-title":"Alzheimers Dement"},{"key":"6848_CR14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/jgh.13785","volume":"32","author":"Y Yasutake","year":"2017","unstructured":"Yasutake Y, Tomita K, Higashiyama M, Furuhashi H, Shirakabe K, Takajo T et al. Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity. J Gastroenterol Hepatol 2017;32:1839\u20131845","journal-title":"J Gastroenterol Hepatol"},{"key":"6848_CR15","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/nu11081911","volume":"11","author":"S Roumeliotis","year":"2019","unstructured":"Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V. Dietary antioxidant supplements and uric acid in chronic kidney disease: a review. Nutrients 2019;11:1911","journal-title":"Nutrients"},{"key":"6848_CR16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","volume":"36","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36:1072\u20131078","journal-title":"Hypertension"},{"key":"6848_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00592-007-0249-3","volume":"44","author":"A Mazza","year":"2007","unstructured":"Mazza A, Zamboni S, Rizzato E, Pessina AC, Tikhonoff V, Schiavon L et al. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetolog 2007;44:99\u2013105","journal-title":"Acta Diabetolog"},{"key":"6848_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12325-014-0175-z","volume":"32","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther 2015;32:31\u201341","journal-title":"Adv Ther"},{"key":"6848_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.abb.2019.01.031","volume":"670","author":"Z Szekanecz","year":"2019","unstructured":"Szekanecz Z, Szamosi S, Kovacs GE, Kocsis E, Benko S. The NLRP3 inflammasome\u2014interleukin 1 pathway as a therapeutic target in gout. Arch Biochem Biophys 2019;670:82\u201393","journal-title":"Arch Biochem Biophys"},{"key":"6848_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jfda.2017.02.003","volume":"25","author":"TY Wong","year":"2017","unstructured":"Wong TY. Smog induces oxidative stress and microbiota disruption. J Food Drug Anal 2017;25:235\u2013244","journal-title":"J Food Drug Anal"},{"key":"6848_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","volume":"152","author":"RB Sartor","year":"2017","unstructured":"Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 2017;152:327\u201339.e4","journal-title":"Gastroenterology"},{"key":"6848_CR22","doi-asserted-by":"publisher","first-page":"16303","DOI":"10.1073\/pnas.212645999","volume":"99","author":"GS Scott","year":"2002","unstructured":"Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A 2002;99:16303\u201316308","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6848_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.14740\/jocmr3289w","volume":"10","author":"M Morimoto","year":"2018","unstructured":"Morimoto M, Hashimoto T, Kitaoka T, Kyotani S. Impact of oxidative stress and newer antiepileptic drugs on the albumin and cortisol value in severe motor and intellectual disabilities with epilepsy. J Clin Med Res 2018;10:137\u2013145","journal-title":"J Clin Med Res"},{"key":"6848_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.14740\/jocmr3670","volume":"11","author":"R Sone","year":"2019","unstructured":"Sone R, Matsuba K, Tahara R, Eda N, Kosaki K, Jesmin S et al. Assessment of salivary nitric oxide levels in elite university athletes in Japan: findings from a cross sectional study design. J Clin Med Res 2019;11:114\u2013120","journal-title":"J Clin Med Res"},{"key":"6848_CR25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/jgh.12980","volume":"30","author":"K Narimatsu","year":"2015","unstructured":"Narimatsu K, Higashiyama M, Kurihara C, Takajo T, Maruta K, Yasutake Y et al. Toll-like receptor (TLR) 2 agonists ameliorate indomethacin-induced murine ileitis by suppressing the TLR4 signaling. J Gastroenterol Hepatol 2015;30:1610\u20131617","journal-title":"J Gastroenterol Hepatol"},{"key":"6848_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00535-016-1205-1","volume":"52","author":"K Yoshikawa","year":"2017","unstructured":"Yoshikawa K, Kurihara C, Furuhashi H, Takajo T, Maruta K, Yasutake Y et al. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling. J Gastroenterol 2017;52:61\u201371","journal-title":"J Gastroenterol"},{"key":"6848_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/archsurg.1970.01340280030009","volume":"101","author":"CJ Chiu","year":"1970","unstructured":"Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg (Chicago, Ill: 1960) 1970;101:478\u201383","journal-title":"Arch Surg (Chicago, Ill: 1960)"},{"key":"6848_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/00365521.2012.690043","volume":"47","author":"M Higashiyama","year":"2012","unstructured":"Higashiyama M, Hokari R, Kurihara C, Ueda T, Watanabe C, Tomita K et al. Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor. Scand J Gastroenterol 2012;47:993\u20131002","journal-title":"Scand J Gastroenterol"},{"key":"6848_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2013.06.007","volume":"714","author":"T Ishida","year":"2013","unstructured":"Ishida T, Miki I, Tanahashi T, Yagi S, Kondo Y, Inoue J et al. Effect of 18beta-glycyrrhetinic acid and hydroxypropyl gammacyclodextrin complex on indomethacin-induced small intestinal injury in mice. Eur J Pharmacol 2013;714:125\u2013131","journal-title":"Eur J Pharmacol"},{"key":"6848_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/mi.2015.89","volume":"9","author":"A Higashimori","year":"2016","unstructured":"Higashimori A, Watanabe T, Nadatani Y, Takeda S, Otani K, Tanigawa T et al. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol 2016;9:659\u2013668","journal-title":"Mucosal Immunol"},{"key":"6848_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3748\/wjg.v21.i1.177","volume":"21","author":"T Ueda","year":"2015","unstructured":"Ueda T, Hokari R, Higashiyama M, Yasutake Y, Maruta K, Kurihara C et al. Beneficial effect of an omega-6 PUFA-rich diet in non-steroidal anti-inflammatory drug-induced mucosal damage in the murine small intestine. World J Gastroenterol 2015;21:177\u2013186","journal-title":"World J Gastroenterol"},{"key":"6848_CR32","first-page":"435","volume":"65","author":"T Tomita","year":"2014","unstructured":"Tomita T, Sadakata H, Tamura M, Matsui H. Indomethacin-induced generation of reactive oxygen species leads to epithelial cell injury before the formation of intestinal lesions in mice. J Physiol Pharmacol Off J Pol Physiol Soc 2014;65:435\u2013440","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"6848_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5009\/gnl18296","volume":"13","author":"T Takajo","year":"2019","unstructured":"Takajo T, Tomita K, Tsuchihashi H, Enomoto S, Tanichi M, Toda H et al. Depression promotes the onset of irritable bowel syndrome through unique dysbiosis in rats. Gut Liver 2019;13:325\u2013332","journal-title":"Gut Liver"},{"key":"6848_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/nu9030196","volume":"9","author":"S Jinno","year":"2017","unstructured":"Jinno S, Toshimitsu T, Nakamura Y, Kubota T, Igoshi Y, Ozawa N et al. Maternal prebiotic ingestion increased the number of fecal bifidobacteria in pregnant women but not in their neonates aged one month. Nutrients 2017;9:196","journal-title":"Nutrients"},{"key":"6848_CR35","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012;6:1621\u20131624","journal-title":"ISME J"},{"key":"6848_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335\u2013336","journal-title":"Nat Methods"},{"key":"6848_CR37","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","volume":"290","author":"JC Gregory","year":"2015","unstructured":"Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2015;290:5647\u20135660","journal-title":"J Biol Chem"},{"key":"6848_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57\u201363","journal-title":"Nature"},{"key":"6848_CR39","doi-asserted-by":"publisher","first-page":"G315","DOI":"10.1152\/ajpgi.2001.280.3.G315","volume":"280","author":"SM Collins","year":"2001","unstructured":"Collins SM. Stress and the gastrointestinal tract IV. Modulation of intestinal inflammation by stress: basic mechanisms and clinical relevance. Am J Physiol Gastrointest Liver Physiol 2001;280:G315\u2013G318","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6848_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ab.2017.12.001","volume":"543","author":"T Furuhashi","year":"2018","unstructured":"Furuhashi T, Sugitate K, Nakai T, Jikumaru Y, Ishihara G. Rapid profiling method for mammalian feces short chain fatty acids by GC-MS. Anal Biochem 2018;543:51\u201354","journal-title":"Anal Biochem"},{"key":"6848_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00535-014-1032-1","volume":"50","author":"SD Syer","year":"2015","unstructured":"Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E et al. NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol 2015;50:387\u2013393","journal-title":"J Gastroenterol"},{"key":"6848_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","volume":"49","author":"DD Heeney","year":"2018","unstructured":"Heeney DD, Gareau MG, Marco ML. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol 2018;49:140\u2013147","journal-title":"Curr Opin Biotechnol"},{"key":"6848_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1574-6941.2008.00527.x","volume":"66","author":"GC Abell","year":"2008","unstructured":"Abell GC, Cooke CM, Bennett CN, Conlon MA, McOrist AL. Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol 2008;66:505\u2013515","journal-title":"FEMS Microbiol Ecol"},{"key":"6848_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/gut.46.1.64","volume":"46","author":"MC Pitcher","year":"2000","unstructured":"Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000;46:64\u201372","journal-title":"Gut"},{"key":"6848_CR45","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010;120:1791\u20131799","journal-title":"J Clin Invest"},{"key":"6848_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol 2013;14:454\u2013460","journal-title":"Nat Immunol"},{"key":"6848_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00535-009-0102-2","volume":"44","author":"K Higuchi","year":"2009","unstructured":"Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009;44:879\u2013888","journal-title":"J Gastroenterol"},{"key":"6848_CR48","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1440-1746.2012.07108.x","volume":"27","author":"YJ Kim","year":"2012","unstructured":"Kim YJ, Kim EH, Hahm KB. Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J Gastroenterol Hepatol 2012;27:1004\u20131010","journal-title":"J Gastroenterol Hepatol"},{"key":"6848_CR49","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/AEM.02340-06","volume":"73","author":"SH Duncan","year":"2007","unstructured":"Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007;73:1073\u20131078","journal-title":"Appl Environ Microbiol"},{"key":"6848_CR50","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780\u201313785","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6848_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.molmed.2016.01.002","volume":"22","author":"N Ijssennagger","year":"2016","unstructured":"Ijssennagger N, van der Meer R, van Mil SWC. Sulfide as a mucus barrier-breaker in inflammatory bowel disease? Trends Mol Med 2016;22:190\u2013199","journal-title":"Trends Mol Med"},{"key":"6848_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/nu9020165","volume":"9","author":"HS Shin","year":"2017","unstructured":"Shin HS, Satsu H, Bae MJ, Totsuka M, Shimizu M. Catechol groups enable reactive oxygen species scavenging-mediated suppression of PKD-NFkappaB-IL-8 signaling pathway by chlorogenic and caffeic acids in human intestinal cells. Nutrients 2017;9:165","journal-title":"Nutrients"},{"key":"6848_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.micinf.2012.11.003","volume":"15","author":"Y Hiramatsu","year":"2013","unstructured":"Hiramatsu Y, Satho T, Irie K, Shiimura S, Okuno T, Sharmin T et al. Differences in TLR9-dependent inhibitory effects of H(2)O(2)-induced IL-8 secretion and NF-kappa B\/I kappa B-alpha system activation by genomic DNA from five Lactobacillus species. Microbes Infect 2013;15:96\u2013104","journal-title":"Microbes Infect"},{"key":"6848_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 2015;6:262","journal-title":"Front Pharmacol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06848-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06848-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06848-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T05:22:39Z","timestamp":1674969759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06848-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6848"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06848-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ryota Hokari received commercial research funding from EA Pharma Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}